Tenofovir alafenamide use in pregnant and lactating women living with HIV-Reference-Cited by-同舟云学术

Tenofovir alafenamide use in pregnant and lactating women living with HIV

Published:2020-03-17 Issue:4 Volume:16 Page:333-342
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Eke Ahizechukwu C.¹²,Brooks Kristina M.³,Gebreyohannes Rahel D.⁴,Sheffield Jeanne S.¹,Dooley Kelly E.⁵,Mirochnick Mark⁶

Affiliation:

1. Division of Maternal Fetal Medicine & Clinical Pharmacology, Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA

2. Doctoral Training Program (Phd), Graduate Training Program in Clinical Investigation (GTPCI), Johns Hopkins University School of Public Health, Baltimore, MD, USA

3. Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

4. Department of Obstetrics & Gynecology, Addis Ababa University College of Health Science, Addis Ababa, Ethiopia

5. Division of Clinical Pharmacology & Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

6. Division of Neonatology, Department of Pediatrics, Boston University School of Medicine, Boston, MA, USA

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2020.1738384

Reference85 articles.

1. Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum

2. Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment

3. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants. The World Health Organization (WHO). [cited 2019 Oct 11]. Available from: https://www.who.int/hiv/pub/mtct/guidelines/en/

4. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Broadening access to tenofovir alafenamide for the treatment and prevention of HIV-1 infection;Expert Review of Clinical Pharmacology;2023-09-07

2. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus;Cochrane Database of Systematic Reviews;2023-06-12

3. Pharmacokinetics of Antiretroviral Agents in Pregnant Individuals Living With HIV: Current Status and Considerations for Study Design and Interpretation;The Journal of Clinical Pharmacology;2023-06

4. Physiologic Changes During Pregnancy and Impact on Small‐Molecule Drugs, Biologic (Monoclonal Antibody) Disposition, and Response;The Journal of Clinical Pharmacology;2023-06

5. Direct antiviral agents (DAAs) and their use in pregnant women with hepatitis C (HCV);Expert Review of Anti-infective Therapy;2022-09-20